Kronos Bio, Inc.
KRONDelisted Jun 20, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001741830
Kronos Bio, Inc. was delisted on Jun 20, 2025; its insiders filed their last Form 4 on Jun 20, 2025; 47 institutions reported holding it in 13F filings for Q1 2025, worth $15.8M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Kronos Bio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- −2 vs. Q4 2023
- Shares held
- 21.7M
- −5.05M (−18.9%) vs. Q4 2023
- Total value
- $28.2M
- −$5.20M (−15.5%) vs. Q4 2023
- New holders
- 5
- 15 more added
- Sold out
- 7
- 17 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 47 | $15.8M |
| Q4 2024 | 56 | $18.7M |
| Q3 2024 | 53 | $19.7M |
| Q2 2024 | 56 | $25.6M |
| Q1 2024 | 58 | $28.2M |
| Q4 2023 | 60 | $33.4M |
| Q3 2023 | 63 | $39.3M |
| Q2 2023 | 80 | $54.3M |
| Q1 2023 | 87 | $47.3M |
| Q4 2022 | 97 | $55.9M |
| Q3 2022 | 96 | $120.8M |
| Q2 2022 | 94 | $134.4M |
| Q1 2022 | 96 | $282.0M |
| Q4 2021 | 81 | $557.8M |
| Q3 2021 | 83 | $811.6M |
| Q2 2021 | 77 | $956.8M |
| Q1 2021 | 71 | $1.05B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Kronos Bio, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 2,905,043 | $3.78M | 0.10% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 2,765,314 | $3.59M | 2.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,948,595 | $2.53M | 0.00% | +247,918+14.6% | Added |
| Millennium Management LLC | 1,827,723 | $2.38M | 0.00% | +979,723+115.5% | Added |
| Alphabet Inc. | 1,438,232 | $1.87M | 0.07% | 00.0% | Unchanged |
| Wildcat Capital Management, LLC | 1,297,959 | $1.69M | 0.61% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,031,530 | $1.34M | 0.00% | +118,604+13.0% | Added |
| Omega Fund Management, LLC | 955,866 | $1.24M | 0.80% | −2,862,417−75.0% | Reduced |
| BlackRock Inc. | 909,450 | $1.18M | 0.00% | −159,054−14.9% | Reduced |
| Artal Group S.A. | 842,954 | $1.10M | 0.03% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 774,559 | $1.00M | 0.00% | +113,618+17.2% | Added |
| Partners Capital Investment Group, LLP | 527,500 | $685.8K | 0.02% | −1,138,297−68.3% | Reduced |
| Geode Capital Management, LLC | 441,225 | $573.7K | 0.00% | +12,703+3.0% | Added |
| Acuitas Investments, LLC | 441,106 | $573.4K | 0.29% | +113,130+34.5% | Added |
| Cerity Partners LLC | 410,796 | $534.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 315,002 | $409.5K | 0.01% | +21,327+7.3% | Added |
| Privium Fund Management (UK) Ltd | 292,182 | $403.2K | 0.20% | 00.0% | Unchanged |
| Choate Investment Advisors | 308,697 | $401.3K | 0.01% | 00.0% | Unchanged |
| CM Management, LLC | 250,000 | $325.0K | 0.27% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 211,800 | $275.3K | 0.00% | −2,900−1.4% | Reduced |
| Citadel Advisors LLC | 189,409 | $246.2K | 0.00% | −8,551−4.3% | Reduced |
| State Street Corp | 178,301 | $231.8K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 132,320 | $172.0K | 0.00% | −5,893−4.3% | Reduced |
| Casdin Capital, LLC | 123,839 | $161.0K | 0.01% | 00.0% | Unchanged |
| Kennedy Capital Management, Inc. | 115,061 | $149.6K | 0.00% | +6,832+6.3% | Added |
| Squarepoint Ops LLC | 107,754 | $140.1K | 0.00% | −45,668−29.8% | Reduced |
| Marquette Asset Management, LLC | 80,369 | $104.5K | 0.02% | +13,269+19.8% | Added |
| Mariner, LLC | 78,800 | $102.4K | 0.00% | +78,800 | New |
| Samsara BioCapital, LLC | 78,131 | $101.6K | 0.02% | 00.0% | Unchanged |
| Forefront Analytics, LLC | 77,131 | $100.3K | 0.05% | +27,963+56.9% | Added |
| Northern Trust Corp | 75,627 | $98.3K | 0.00% | −17,046−18.4% | Reduced |
| Jacobs Levy Equity Management, Inc | 59,398 | $77.2K | 0.00% | −234,132−79.8% | Reduced |
| Gsa Capital Partners LLP | 57,347 | $75.0K | 0.01% | +32,201+128.1% | Added |
| Virtu Financial LLC | 54,592 | $71.0K | 0.01% | +54,592 | New |
| Coastal Bridge Advisors, LLC | 51,968 | $67.6K | 0.02% | 00.0% | Unchanged |
| Cornercap Investment Counsel Inc | 41,351 | $53.8K | 0.01% | 00.0% | Unchanged |
| XTX Topco Ltd | 40,815 | $53.1K | 0.01% | +8,783+27.4% | Added |
| HSBC Holdings PLC | 38,368 | $49.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 37,837 | $49.2K | 0.00% | −700−1.8% | Reduced |
| Cubist Systematic Strategies, LLC | 30,291 | $39.4K | 0.00% | +30,291 | New |
| Bluefin Capital Management, LLC | 25,100 | $32.6K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 20,645 | $26.8K | 0.00% | +20,645 | New |
| Jane Street Group, LLC | 18,409 | $23.9K | 0.00% | −670−3.5% | Reduced |
| Goldman Sachs Group Inc | 17,895 | $23.3K | 0.00% | −1,748−8.9% | Reduced |
| Barclays PLC | 16,128 | $21.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,189 | $19.7K | 0.00% | +15,117+20,995.8% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 12,246 | $15.9K | 0.00% | +12,246 | New |
| Pathstone Holdings, LLC | 11,984 | $15.6K | 0.00% | −50−0.4% | Reduced |
| Bank of America Corp | 5,744 | $7.47K | 0.00% | −29−0.5% | Reduced |
| Simplex Trading, LLC | 5,190 | $6.00K | 0.00% | +4,499+651.1% | Added |
| FMR LLC | 3,200 | $4.16K | 0.00% | −362,000−99.1% | Reduced |
| Rhumbline Advisers | 2,088 | $2.71K | 0.00% | 00.0% | Unchanged |
| Dakota Community Bank & Trust NA | 943 | $1.23K | 0.01% | 00.0% | Unchanged |
| Citigroup Inc | 400 | $520 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 350 | $455 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 347 | $451 | 0.00% | +6+1.8% | Added |
| Qube Research & Technologies Ltd | 297 | $386 | 0.00% | −1,577−84.2% | Reduced |
| Royal Bank of Canada | 110 | $0 | 0.00% | −101−47.9% | Reduced |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,752,745−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −254,987−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −45,443−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −16,618−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −16,150−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −15,260−100.0% | Sold out |